Full Text View
Tabular View
No Study Results Posted
Related Studies
BSSPlus Versus Lactated Ringer's for Phacoemulsification
This study has been completed.
First Received: December 2, 2008   Last Updated: December 15, 2008   History of Changes
Sponsored by: University of Sao Paulo
Information provided by: University of Sao Paulo
ClinicalTrials.gov Identifier: NCT00801359
  Purpose

Two intraocular irrigating solutions (BSSPlus versus Lactated Ringer's) are compared in this prospective, randomized, masked trial to investigate for differences in preservation of corneal integrity after phacoemulsification cataract surgery.


Condition Intervention Phase
Cataract
Procedure: Phacoemulsification
Drug: BSSPlus solution
Drug: Lactated Ringer's solution
Phase II

MedlinePlus related topics: Cataract
Drug Information available for: Ringer's lactate Ringer's solution
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Comparison of Corneal Changes After Phacoemulsification Using BSSPlus Versus Lactated Ringer's Irrigating Solution

Further study details as provided by University of Sao Paulo:

Primary Outcome Measures:
  • endothelial cell density [ Time Frame: baseline and at 1, 8, 15, 30 and 60 days postoperatively ] [ Designated as safety issue: Yes ]
  • central corneal thickness [ Time Frame: baseline and at 1, 8, 15, 30 and 60 days postoperatively ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • number of anterior chamber cells and flare grade [ Time Frame: baseline and at 1, 8, 15, 30 and 60 days postoperatively ] [ Designated as safety issue: Yes ]

Enrollment: 110
Study Start Date: January 2008
Study Completion Date: October 2008
Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
BSSplus: Active Comparator Procedure: Phacoemulsification Drug: BSSPlus solution
Ringer: Experimental Procedure: Phacoemulsification Drug: Lactated Ringer's solution

  Eligibility

Ages Eligible for Study:   50 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with senile cataract
  • Visual acuity between 20/400 and 20/40

Exclusion Criteria:

  • Presence of corneal opacity
  • Presence of corneal disease
  • Traumatic, toxic, hereditary (congenital)and complicated cataracts(uveitis)
  • Anterior chamber cells or flare detected before surgery
  • Previous ocular surgery
  • Any condition which may affect documentation or follow-up
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00801359

Locations
Brazil, São Paulo
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto; Centro Avançado de Retina e Catarata
Ribeirão Preto, São Paulo, Brazil, 14049-900
Sponsors and Collaborators
University of Sao Paulo
  More Information

Publications:
Responsible Party: University of São Paulo ( Rodrigo Jorge )
Study ID Numbers: 8657/2007
Study First Received: December 2, 2008
Last Updated: December 15, 2008
ClinicalTrials.gov Identifier: NCT00801359     History of Changes
Health Authority: Brazil: Ethics Committee

Keywords provided by University of Sao Paulo:
cataract
phacoemulsification
irrigation solution
endothelial cell density
corneal thickness

Study placed in the following topic categories:
Eye Diseases
Cataract
Lens Diseases

Additional relevant MeSH terms:
Eye Diseases
Cataract
Lens Diseases

ClinicalTrials.gov processed this record on May 07, 2009